0
edits
Changes
no edit summary
<tr>
<td><strong> CD31</strong></td>
<td> 130-140</td> <td> GPiia, endocam, platelet endothelial cell adhesion molecule <br /> (PECAM-1) </td> <td> Endothelial cells, platelets, monocytes, neutrophils, NK cells, subsets of T cells </td> <td> Adhesion molecule </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD32</strong></td>
<td bgcolor="#cccccc"> 40</td> <td bgcolor="#cccccc"> FCRⅡ, FcγRⅡ </td> <td bgcolor="#cccccc"> B cells, granulocytes, monocytes</td> <td bgcolor="#cccccc"> Receptor for Fc portion of antigen-antibody-complexed IgG molecules </td>
</tr>
<tr>
<td><strong> CD33</strong></td>
<td> 67</td> <td> gp67, p67</td> <td> Monocytes, myeloid precursors </td> <td> Sialic acid-dependent cytoadhesion molecule, a sialoadhesion </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD34</strong></td>
<td bgcolor="#cccccc"> 40 (based on amino seq.)</td> <td bgcolor="#cccccc"> gp105-120 </td> <td bgcolor="#cccccc"> Early lymphohematopoeitic stem and progenitor cells, small-vessel endothelial cells, embryonic fibroblasts, some cells in fetal and adult nervous tissue </td> <td bgcolor="#cccccc"> Cell-cell adhesion molecule </td>
</tr>
<tr>
<td><strong> CD35</strong></td>
<td> Many forms: 160, 190, 220, 250, 165, 195, 225, 255</td> <td> C3bR, C4bR, complement receptor type one (CR1), immune adherence receptor </td> <td> Erythrocytes, neutrophils, monocytes, eosinophils, B cells </td> <td> Receptor for C4b/C3b particles, mediating their adherence and phagocytosis; facilitator of C3b and C4b cleavage, thus limiting complement activation </td>
</tr>
<tr>